JP2023098936A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023098936A5 JP2023098936A5 JP2023061251A JP2023061251A JP2023098936A5 JP 2023098936 A5 JP2023098936 A5 JP 2023098936A5 JP 2023061251 A JP2023061251 A JP 2023061251A JP 2023061251 A JP2023061251 A JP 2023061251A JP 2023098936 A5 JP2023098936 A5 JP 2023098936A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- macular degeneration
- dry
- eye disease
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2017-0061250 | 2017-05-17 | ||
| KR20170061250 | 2017-05-17 | ||
| JP2019563617A JP7680824B2 (ja) | 2017-05-17 | 2018-05-17 | 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019563617A Division JP7680824B2 (ja) | 2017-05-17 | 2018-05-17 | 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023098936A JP2023098936A (ja) | 2023-07-11 |
| JP2023098936A5 true JP2023098936A5 (enExample) | 2025-06-13 |
| JP7775250B2 JP7775250B2 (ja) | 2025-11-25 |
Family
ID=64566301
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019563617A Active JP7680824B2 (ja) | 2017-05-17 | 2018-05-17 | 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物 |
| JP2023061251A Active JP7775250B2 (ja) | 2017-05-17 | 2023-04-05 | 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019563617A Active JP7680824B2 (ja) | 2017-05-17 | 2018-05-17 | 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12037415B2 (enExample) |
| EP (1) | EP3643723B1 (enExample) |
| JP (2) | JP7680824B2 (enExample) |
| KR (2) | KR102287226B1 (enExample) |
| CN (1) | CN110945012A (enExample) |
| AU (1) | AU2018281617B2 (enExample) |
| BR (1) | BR112019024040A2 (enExample) |
| CA (1) | CA3063842A1 (enExample) |
| ES (1) | ES2982308T3 (enExample) |
| MX (1) | MX2019013799A (enExample) |
| RU (1) | RU2766160C2 (enExample) |
| SG (1) | SG11201912110YA (enExample) |
| WO (1) | WO2018225961A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12037415B2 (en) * | 2017-05-17 | 2024-07-16 | Yuyu Pharma, Inc. | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
| TWI865470B (zh) * | 2018-11-14 | 2024-12-11 | 南韓商柳柳製藥股份有限公司 | 治療眼睛疾病之肽及醫藥組合物 |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| BR112021023477A2 (pt) * | 2019-05-21 | 2022-02-15 | Eyebio Korea | Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório |
| KR20210104460A (ko) * | 2020-02-17 | 2021-08-25 | 주식회사 아이바이오코리아 | 고체상 합성법을 이용한 펩타이드의 제조 방법 |
| WO2021191689A2 (en) * | 2020-03-05 | 2021-09-30 | Yuyu Pharma, Inc. | Treatment of inflammatory diseases with peptides and pharmaceutical compositions |
| MX2024006997A (es) * | 2021-12-13 | 2024-06-19 | Eyebiokorea Inc | Composicion para el tratamiento de la degeneracion macular que comprende un nuevo peptido. |
| KR102593936B1 (ko) * | 2021-12-13 | 2023-10-27 | 주식회사 아이바이오코리아 | 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물 |
| KR102587729B1 (ko) * | 2023-02-27 | 2023-10-12 | 주식회사 아이바이오코리아 | 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물 |
| KR102673860B1 (ko) * | 2023-08-10 | 2024-06-12 | (주)케어젠 | 안구 건조증의 개선 활성을 갖는 펩타이드 및 이의 용도 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| WO2007117444A2 (en) * | 2006-03-31 | 2007-10-18 | Yinghe Hu | Protein detection by aptamers |
| WO2009039854A2 (en) | 2007-09-27 | 2009-04-02 | Dako Denmark A/S | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| US20090131303A1 (en) * | 2007-11-16 | 2009-05-21 | Bor-Shyue Hong | Methods and compositions for treating dry eye |
| JP4490498B2 (ja) * | 2008-09-30 | 2010-06-23 | 新田ゼラチン株式会社 | 疾病抑制剤 |
| UA113627C2 (xx) | 2011-05-27 | 2017-02-27 | Кристалічна форма циклоспорину a, фармацевтична композиція та спосіб лікування | |
| WO2013079213A1 (en) | 2011-11-30 | 2013-06-06 | Xigen Inflammation Ltd. | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome |
| KR101438744B1 (ko) | 2012-08-02 | 2014-09-15 | 전남대학교산학협력단 | 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물 |
| KR101948156B1 (ko) | 2013-12-10 | 2019-02-14 | 인제대학교 산학협력단 | 알칼리 화상을 이용한 각막 혼탁증 동물모델 및 각막 혼탁증 예방 또는 치료용 약학조성물 |
| KR101555296B1 (ko) | 2013-12-10 | 2015-09-23 | 인제대학교 산학협력단 | 연골세포 유래 세포외 기질을 유효성분으로 함유하는 건성안 예방 또는 치료용 약학조성물 |
| KR101721059B1 (ko) | 2014-12-26 | 2017-03-30 | 주식회사 아이바이오코리아 | 안구 표면 질환 예방 또는 치료용 약학조성물 |
| KR101690539B1 (ko) | 2015-07-30 | 2016-12-29 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| AU2016373364B2 (en) | 2015-12-14 | 2019-07-11 | Tsung-Chuan Ho | Short synthetic peptide and uses thereof |
| KR101798183B1 (ko) * | 2016-04-08 | 2017-11-15 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| ES2822289T3 (es) | 2016-04-08 | 2021-04-30 | Eyebio Korea | Péptido a base de colágeno tipo II alfa-1 para su uso en el tratamiento de la degeneración macular |
| KR101795653B1 (ko) * | 2016-05-19 | 2017-11-09 | 인제대학교 산학협력단 | 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물 |
| KR20180074928A (ko) | 2016-12-26 | 2018-07-04 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 동물 의약품 조성물 |
| US12037415B2 (en) | 2017-05-17 | 2024-07-16 | Yuyu Pharma, Inc. | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
| TWI865470B (zh) * | 2018-11-14 | 2024-12-11 | 南韓商柳柳製藥股份有限公司 | 治療眼睛疾病之肽及醫藥組合物 |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| WO2021191689A2 (en) * | 2020-03-05 | 2021-09-30 | Yuyu Pharma, Inc. | Treatment of inflammatory diseases with peptides and pharmaceutical compositions |
-
2018
- 2018-05-17 US US16/614,123 patent/US12037415B2/en active Active
- 2018-05-17 EP EP18812841.7A patent/EP3643723B1/en active Active
- 2018-05-17 SG SG11201912110YA patent/SG11201912110YA/en unknown
- 2018-05-17 WO PCT/KR2018/005673 patent/WO2018225961A1/ko not_active Ceased
- 2018-05-17 BR BR112019024040-3A patent/BR112019024040A2/pt unknown
- 2018-05-17 ES ES18812841T patent/ES2982308T3/es active Active
- 2018-05-17 CA CA3063842A patent/CA3063842A1/en active Pending
- 2018-05-17 JP JP2019563617A patent/JP7680824B2/ja active Active
- 2018-05-17 RU RU2019141646A patent/RU2766160C2/ru active
- 2018-05-17 AU AU2018281617A patent/AU2018281617B2/en active Active
- 2018-05-17 KR KR1020180056745A patent/KR102287226B1/ko active Active
- 2018-05-17 CN CN201880047540.1A patent/CN110945012A/zh active Pending
- 2018-05-17 MX MX2019013799A patent/MX2019013799A/es unknown
-
2021
- 2021-07-30 KR KR1020210100394A patent/KR102498428B1/ko active Active
-
2023
- 2023-04-05 JP JP2023061251A patent/JP7775250B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7162708B2 (ja) | 医薬組成物 | |
| JP2024071370A5 (enExample) | ||
| JP2021098728A5 (enExample) | ||
| JP2023506532A5 (enExample) | ||
| JP2021191784A5 (enExample) | ||
| JP2024156774A5 (enExample) | ||
| JP2024540183A5 (enExample) | ||
| RU2632107C2 (ru) | Пероральная фармацевтическая композиция для профилактики или лечения синдрома "сухого глаза", содержащая ребамипид или его предшественник | |
| JP2023116489A5 (enExample) | ||
| JP2013500977A5 (enExample) | ||
| JP2021516685A5 (enExample) | ||
| JP2025161856A5 (enExample) | ||
| JP6480640B2 (ja) | イマチニブを有効成分として含む眼球乾燥疾患予防及び治療用薬学組成物 | |
| JP2019536812A5 (enExample) | ||
| JP2022552520A5 (enExample) | ||
| JP2025502064A5 (enExample) | ||
| JP2021534160A5 (enExample) | ||
| AU2020349041A1 (en) | Combination treatment with a p53 reactivator and an inhibitor of an antiapoptotic Bcl-2 family protein | |
| JP2026041886A5 (enExample) | ||
| JP2022551691A5 (enExample) | ||
| JP2024516359A5 (enExample) | ||
| JP2022520832A5 (enExample) | ||
| RU2017140495A (ru) | Композиции, содержащие анакинра | |
| JP2024524933A5 (enExample) | ||
| JP2024149756A (ja) | 角膜上皮創傷治癒促進用の眼科用組成物 |